Ferritin, Iron Homeostasis and Cellular Stress
铁蛋白、铁稳态和细胞压力
基本信息
- 批准号:7891073
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-17 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntioxidantsBinding ProteinsCellsCellular StressChemopreventive AgentComplexDiseaseElementsFOS geneFerritinH ferritinHealthHistone DeacetylationHomeostasisIronIron-Binding ProteinsKnockout MiceMapsMediatingMethodsMolecularMolecular BiologyMolecular WeightOxidantsOxidative StressPathway interactionsPhenotypePredispositionReactive Oxygen SpeciesRegulationRepressionResponse ElementsRoleStimulusStressStructureTP53 geneTestingTetracyclinesTissuesTransgenic MiceTransgenic OrganismsTumor Necrosis Factor-alphaTumor Necrosis FactorsXenobioticscytokinein vivomouse modelmutantpromoterresponseresponse to injuryvector
项目摘要
DESCRIPTION (provided by applicant): The metallochemistry and molecular biology
of iron converge in the study of ferritin structure and function. Ferritin is
an iron binding protein whose regulation, once thought to be responsive only to
changes in cellular iron content, has more recently been shown to be targeted
by stress-induced stimuli, including cytokines, oxidants, and a range of
xenobiotics. We now know that agents such as tumor necrosis factor, reactive
oxygen species, and other stimuli trigger ferritin induction; ferritin, in
turn, alters cellular iron homeostasis by sequestering reactive, "low molecular
weight" cellular iron. This in turn reduces susceptibility to subsequent
stress. In this proposal we explore the hypothesis that ferritin regulation is
instrumental in modulating the magnitude and character of the cellular response
to injury and stress. We examine the unique contribution of ferritin to the
phenotype of cells and tissues exposed to prooxidants and antioxidants. In our
first Specific Aim, we explore the molecular mechanisms by which ferritin
participates in the chemopreventive response to prooxidant xenobiotics. In our
second Specific Aim, we explore potential pathways by which oxidative stress
regulates ferritin in health and disease. In our third Specific Aim, we develop
in vivo mouse models to test the relevance of our findings in the context of
whole animals.
描述(申请人提供):金属化学和分子生物学
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANK M. TORTI其他文献
FRANK M. TORTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANK M. TORTI', 18)}}的其他基金
Targeting sideroflexin 4, a mitochondrial inner membrane protein involved iniron sulfur cluster biogenesis, to enhance the efficacy of DNA-damaging drugs inovarian cancer
靶向铁弹性蛋白 4(一种参与铁硫簇生物发生的线粒体内膜蛋白),以增强 DNA 损伤药物卵巢癌的疗效
- 批准号:
10063489 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
Targeting sideroflexin 4, a mitochondrial inner membrane protein involved iniron sulfur cluster biogenesis, to enhance the efficacy of DNA-damaging drugs inovarian cancer
靶向铁弹性蛋白 4(一种参与铁硫簇生物发生的线粒体内膜蛋白),以增强 DNA 损伤药物卵巢癌的疗效
- 批准号:
10529292 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
Targeting sideroflexin 4, a mitochondrial inner membrane protein involved iniron sulfur cluster biogenesis, to enhance the efficacy of DNA-damaging drugs inovarian cancer
靶向铁弹性蛋白 4(一种参与铁硫簇生物发生的线粒体内膜蛋白),以增强 DNA 损伤药物卵巢癌的疗效
- 批准号:
9887273 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
Targeting sideroflexin 4, a mitochondrial inner membrane protein involved iniron sulfur cluster biogenesis, to enhance the efficacy of DNA-damaging drugs inovarian cancer
靶向铁弹性蛋白 4(一种参与铁硫簇生物发生的线粒体内膜蛋白),以增强 DNA 损伤药物卵巢癌的疗效
- 批准号:
10304862 - 财政年份:2019
- 资助金额:
$ 10万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Scientific Research (C)